Megaphone Eyewire headlines are now available as a weekly podcast! Listen Now

Now Playing

Eyewire TV July 29, 2026 thumbnail

Introduction

story 1 thumbnail

Outlook Therapeutics CEO Discusses FDA Approval of Lytenava for Wet AMD

story 2 thumbnail

Roche Receives Positive Opinion from EMA Committee for Wet AMD Treatment Susvimo

story 3 thumbnail

Glaukos Completes Enrollment in Pivotal Trial Evaluating Preserflo MicroShunt for POAG


Previous EyewireTV Episodes